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Preface
This surveillance report provides information on the occurrence of  blood borne viral and 
sexually transmissible infections (STIs) among the Aboriginal and Torres Strait Islander 
population in Australia. The report is published by the Kirby Institute for the purposes of  
stimulating and supporting discussion on ways to minimise the risk of  transmission as well 
as the personal and social consequences of  these infections within Aboriginal and Torres 
Strait Islander communities.
This Report is published annually as an accompanying document to the report HIV, viral 
hepatitis and sexually transmissible infections in Australia Annual Surveillance Report and is 
overseen by National Aboriginal Community Controlled Health Organisation (NACCHO) and 
the Annual Surveillance Report Advisory Committee.
The report is produced in a format that is intended to be accessible to a wide range of  
health service providers and consumers, and particularly Aboriginal and Torres Strait 
Islander health services and communities. It is available in hard copy and at  
http://www.kirby.unsw.edu.au
Unless specifically stated otherwise, all data provided in this report are to the end of  2013, as 
reported by 31 March 2014. Data in the report are provisional and subject to future revision.
The report could not have been prepared without the collaboration of  a large number of  
organisations involved in health services throughout Australia. The ongoing contribution of  
these organisations, listed from page 3 onwards, is gratefully acknowledged.
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Medical and epidemiological terms
Chlamydia: A sexually transmissible infection caused by a bacterium (Chlamydia trachomatis). The infection is 
asymptomatic in about 80% of  cases. In those with symptoms, the infection cause inflammation of  the urethra, 
causing some pain and penile discharge, and in females the main symptoms are intermenstrual bleeding and 
dysuria. Complications of  infection are particularly serious for females and can include pelvic inflammatory 
disease, ectopic pregnancy and infertility. Chlamydia is fully curable by a single dose of  antibiotics.
Donovanosis: A sexually transmissible infection caused by a bacterium (Calymmatobacterium granulomatis). 
The most common symptom is large, painless ulcers of  the genitals, the groin or the anal region. The lesions can 
progress and become complicated by other bacterial infections if  untreated, ultimately leading to serious damage 
to the affected part of  the body, and even becoming life-threatening. Donovanosis is fully curable by 3 to 4 doses 
of  antibiotics over a month. Donovanosis occurs in central and northern Australia, and is now very rare.
Gonorrhoea: A sexually transmissible infection caused by a bacterium (Neisseria gonorrhoea). The infection is 
asymptomatic in about 80% of  women, and 50% of  men. Symptoms are similar to those of  chlamydia, as are 
the complications. Most males with urethral gonorrhoea will eventually develop symptoms. Gonorrhoea is fully 
curable by a single dose of  antibiotics.
HBV (hepatitis B virus) infection: An infection caused by a virus that is transmissible by sexual and blood 
contact, as well as from mother to child at birth. Newly diagnosed HBV infection means that a person previously 
not known to have the infection has been tested and now found to have the infection. Newly acquired infection 
means the person has become infected within the past two years.
HCV (hepatitis C virus) infection: An infection caused by a virus that is transmissible by blood contact as well 
as from mother to child. Newly diagnosed HCV infection means that a person previously not known to have the 
infection has been tested and now found to have the infection. Newly acquired means the person has become 
infected within the past two years.
HIV (human immunodeficiency virus) infection: An infection caused by a virus that is transmissible by sexual 
and blood contact, as well as from mother to child. HIV infection is the cause of  AIDS. Newly diagnosed HIV 
infection means that a person previously not known to have the infection has been tested and now found to have 
the infection. Newly acquired HIV infection means the person has become infected within the past year.
Infectious syphilis: A sexually transmissible infection caused by a bacterium (Treponema pallidum). The main 
symptoms in the early stage are a painless sore at the site of  infection within the first few weeks, followed by 
a rash over the next several months. In the absence of  treatment, there will then be a period of  several years 
without any symptoms, with a chance of  a range of  complications over decades that can involve the skin, bone, 
the central nervous system and cardiovascular system. Infectious syphilis is fully curable with a single injection 
of  long acting penicillin.
For more information on these infections, see the National Management Guidelines for Sexually Transmitted 
Infections 7th Edition.
Age specific rate: The proportion of  cases in a particular age group who have the infection, usually expressed 
per 100 000 cases in the specified age group.
Example: Age–specific notification rate of  diagnosis of  gonorrhoea among males aged 20 – 29 years
Number of  diagnoses of  gonorrhoea among males aged 20 – 29 years  
X 100000
 Number of  males aged 20 – 29 years
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Age standardised rate of infection: The proportion of  notifications in a particular population who have the 
infection, adjusted by a mathematical technique to account for the age structure so that comparisons can be 
made across populations.
Area of residence: Area of  residence, indicated by postcode, is classified into one of  five areas: major cities, 
inner regional, outer regional, remote and very remote. In 2013, 65% of  the Aboriginal and Torres Strait Islander 
population lived in outer regional, remote and very remote areas combined and 35% in major cities (Figure 1); 
compared with 29% and 71% of  the non-Indigenous population respectively (Figure 1) (See Methodological 
Notes for further information).
Figure 1 Area of residence, 2013, by Aboriginal and Torres Strait Islander status
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Completeness of data on Aboriginal and Torres Strait Islander status
Incomplete information on Aboriginal and Torres Strait Islander identification has the potential to underestimate 
the true extent of  these infections in the Aboriginal and Torres Strait Islander population.
In 2013, all jurisdictions reported Aboriginal and Torres Strait Islander status for greater than 50% of  diagnoses 
of  HIV, infectious syphilis, gonorrhoea, newly acquired HBV and newly acquired HCV diagnoses. However 
Aboriginal and Torres Strait Islander status was reported for less than 50% of  diagnoses in the following 
jurisdictions (Figure 2, 3):
• Chlamydia: Australian Capital Territory, New South Wales and Victoria
• Newly diagnosed HBV: New South Wales, Victoria and Queensland
• Newly diagnosed HCV: Australian Capital Territory, Victoria and Queensland.
Time trends in diagnoses of  specific infections by jurisdiction were included in the Surveillance and Evaluation 
Report 2013 if  information on Aboriginal and Torres Strait Islander status was available for at least 50% of  
diagnoses of  the infection in every one of  the past five years. Therefore there may be jurisdictions who met the 
50% threshold in 2013 but not in other years, and thus their data were not in included in this report (Table 2).
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Figure 2 Reporting of Aboriginal and Torres Strait Islander status at notification of selected sexually 
transmissible infections, by State/Territory, 2013
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Figure 3 Reporting of Aboriginal and Torres Strait Islander status at notification of viral hepatitis 
diagnoses, by State/Territory, 2013
0
25
50
75
100
WAVICTASSAQLDNTNSWACT
STATE/TERRITORY
Newly acquired hepatitis B Newly Diagnosed Hepatitis B Newly acquired hepatitis C Newly Diagnosed Hepatitis C
%
 O
F 
NO
TI
FI
CA
TI
ON
S 
RE
PO
RT
IN
G 
AB
OR
IG
IN
AL
AN
D 
TO
RR
ES
 S
TR
AI
T 
IS
LA
ND
ER
 S
TA
TU
S
10 Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
11Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
2014
Bloodborne viral and sexually transmitted infections 
in Aboriginal and Torres Strait Islander people:
Surveillance and Evaluation Report 
Summary
• Overall, the Aboriginal and/or Torres Strait Islander population continue to be overrepresented in notifications 
of  STIs and viral hepatitis.
• Chlamydia and gonorrhoea notifications continue to be reported at disproportionately high rates among the 
Aboriginal and Torres Strait Islander population, with 28% of  gonorrhoea notifications among the Aboriginal 
and Torres Strait Islander population.
• Overall notifications of  chlamydia and gonorrhoea have plateaued since 2010, with variation by jurisdiction 
- increasing in Northern Territory and South Australia in 2013, and declining in Queensland and Western 
Australia since 2011.
• The elimination of  donovanosis from Australia is on track, with no cases detected in 2011; one in 2012; and 
none in 2013.
• Infectious syphilis notifications decreased in the Aboriginal and Torres Strait Islander population in 2013, 
particularly in 15 – 19 year olds and in Northern Territory, Queensland and Western Australia. There has 
been an increase in syphilis in the non-Indigenous population.
• Young Aboriginal and Torres Strait Islander people aged 15 – 19 years and Aboriginal and Torres Strait 
Islander people living in outer regional, remote and very remote communities continue to experience 
substantially higher rates of  chlamydia, gonorrhoea and infectious syphilis.
•  In 2013, new HIV diagnoses were notified at a higher rate in the Aboriginal and/or Torres Strait Islander 
population than the non-Indigenous Australian-born population. A higher proportion of  diagnoses in the 
past five years in the Aboriginal and/or Torres Strait Islander population are due to injecting drug use (12%) 
than the non-Indigenous Australian-born population (3%), and heterosexual contact (21% vs. 13%).
• Notifications of  newly diagnosed HBV and HCV infections are reported at disproportionately high rates 
among the Aboriginal and Torres Strait Islander population.
• There was a decline in rates of  newly diagnosed HBV and an increase in the notification rate of  newly 
diagnosed HCV infections in the Aboriginal and Torres Strait Islander population.
Sexually transmissible infections
• Chlamydia continued to be the most frequently reported notifiable disease in Australia with 82 537 
notifications in 2013. Of  these, 6 629 (8%) were among the Aboriginal and Torres Strait Islander population, 
34 344 (41%) were among the non-Indigenous population and Indigenous status was not reported for 
41 564 (51%) notifications.
•  The chlamydia notification rate in the Aboriginal and Torres Strait Islander population in 2013 of  1 207 per 
100 000 was 3 times higher than the rate of  379 per 100 000 in the non-Indigenous population.
• 81% of  chlamydia notifications in 2013 in both populations occurred in the 15 - 19 and 20 - 29 year age groups.
• Male to female ratios of  chlamydia notifications for the Aboriginal and Torres Strait Islander population and 
the non-Indigenous population were 0.5:1 and 0.7:1, respectively.
• Chlamydia notifications reported from remote and very remote areas accounted for 45% of  all notifications in 
the Aboriginal and Torres Strait Islander population.
• Of  the 14 947 notifications of  gonorrhoea in 2013, 4 052 (27%) were among the Aboriginal and Torres Strait 
Islander population, 6 567 (44%) were among the non-Indigenous population and Indigenous status was not 
reported for 4 197 (29%) notifications.
• The rate of  gonorrhoea notifications in the Aboriginal and Torres Strait Islander population in 2013 was 694 
per 100 000, 14 times higher than the rate of  48 per 100 000 in the non-Indigenous population.
12 Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
• Male to female ratios of  gonorrhoea notifications for Aboriginal and Torres Strait Islander and the 
non-Indigenous population were 0.8:1 and 4:1, respectively.
• There were no donovanosis notifications in Australia in 2011, one in 2012, and none in 2013, demonstrating 
success in the efforts to eliminate this disease from Australian populations.
• Nationally, there were 1 764 notifications of  infectious syphilis in 2013; 142 (8%) among the Aboriginal and 
Torres Strait Islander population, 1 457 (83%) among the non-Indigenous population and Indigenous status 
was not reported for 165 (9%) notifications.
• The notification rate of  infectious syphilis in the Aboriginal and Torres Strait Islander population in 2013 was 
18 per 100 000, close to 3 times higher than the rate of  7 per 100 000 in the non-Indigenous population.
• The notification rate of  infectious syphilis declined in 2011 – 2013, after an increase in the notification rate of  
infectious syphilis in the Aboriginal and Torres Strait Islander population in 2010 attributed to an outbreak of  
syphilis in some Queensland remote communities. In the Northern Territory there has been a substantial decline 
since 2010 and a decline in Western Australia and South Australia since 2011, and Queensland since 2012.
HIV infection
• There were a total of  1 236 notifications of  newly diagnosed HIV infection in 2013; 26 diagnoses were 
among the Aboriginal and Torres Strait Islander population.
• In the 10 years from 2004 – 2013, there were 231 notifications of  newly diagnosed HIV infection in the 
Aboriginal and Torres Strait Islander population.
• In 2013, the notification rate of  newly diagnosed HIV infection in the Aboriginal and Torres Strait Islander 
population (4.9 per 100 000) was 1.3 times higher than the non-Indigenous Australian-born population (3.9 
per 100 000).
• Among notifications of  newly diagnosed HIV infection in 2009 - 2013, the most frequently reported route of  
HIV transmission was sexual contact between males in both the Aboriginal and Torres Strait Islander (51%) 
and non-Indigenous Australian-born populations (76%).
• A higher proportion of  notifications in 2009 – 2013 from the Aboriginal and Torres Strait Islander populations 
were attributed to injecting drug use (12% vs. 3%) and heterosexual contact (21% vs. 13%) and among 
females (20% vs 5%) respectively compared with the non-Indigenous Australian-born population.
HBV infection
• A total of  7 151 cases of  newly diagnosed HBV infection were notified in Australia in 2013; of  these 206 
(3%) were among the Aboriginal and Torres Strait Islander population, 2 693 (38%) were among the 
non-Indigenous population and Indigenous status was not reported for 4 252 (59%) notifications.
• In 2013, the notification rate of  newly diagnosed HBV infection for the Aboriginal and Torres Strait Islander 
population was around 2 times higher than the non-Indigenous population (72 per 100 000 versus 32 per 
100 000).
• In the period 2009 – 2013, there was a 28% decline in the notification rate of  newly diagnosed HBV infection 
in the Aboriginal and Torres Strait Islander population (from 100 per 100 000 in 2009, to 72 per 100 000 in 
2013), with a 10% increase in rates in the non-Indigenous population (from 29 per 100 000 in 2009, to 32 
per 100 000 in 2013).
• There were 172 newly acquired HBV infections notified in 2013; 13 (8%) were among the Aboriginal and 
Torres Strait Islander population, 130 (76%) were among the non-Indigenous population and Indigenous 
status was not reported for 29 (17%) notifications.
• In 2013, the notification rate of  newly acquired HBV infection in the Aboriginal and Torres Strait Islander 
population was 1.9 per 100 000 compared to 0.7 per 100 000 in the non-Indigenous population.
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HCV infection
• A total of  10 715 cases of  newly diagnosed HCV infection were reported in Australia in 2013; 796 
(7%) occurred among the Aboriginal and Torres Strait Islander population, 3 596 (34%) among the 
non-Indigenous population and Indigenous status was not reported for 6323 (59%) notifications.
• The rate of  newly diagnosed HCV infection in the Aboriginal and Torres Strait Islander population was 142 
per 100 000, 3 times higher than the 41 per 100 000 in the non-Indigenous population.
• There was a 29% increase in the notification rate of  newly diagnosed HCV infection in the Aboriginal and 
Torres Strait Islander population whereas the rate in the non-Indigenous population remained steady.
Table 1 Aboriginal and Torres Strait Islander population in Australia, 2013, by State/Territory
State/Territory
Estimated resident 
population Number1
ACT 6561
NSW 216 212
NT 70 702
QLD 198 900
SA 38 951
TAS 25 281
VIC 49 904
WA 91 800
Total 698 311
1 Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 2001-2026
Source: Australian Bureau of Statistics
Table 2 Number and rate1 of notifications of sexually transmissible infections and viral hepatitis in 
Australia2, 2013, by Aboriginal and Torres Strait Islander status
Notifications of sexually
transmissible infections and viral hepatitis
Aboriginal and Torres  
Strait Islander Non-Indigenous
 Number1 Rate2  Number3 Rate2 Excluded jurisdictions4
Chlamydia 6629 1207 34 344 379 ACT, NSW, VIC
Gonorrhoea 4052 694 6661 48 NSW
Infectious syphilis 142 18 1622 7 Nil
HIV infection 26 5 1194 4 Nil
Newly acquired HBV infection 13 2 130 1 Nil
Newly diagnosed HBV infection 206 72 2693 32 NSW, VIC, QLD
Newly acquired HCV infection 72 10 273 2 Nil
Newly diagnosed HCV infection 796 142 3596 41 ACT, NSW, VIC, QLD
1 Health jurisdictions in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses in each of  the past five years.
2 Age standardised rate per 100 000 population.
3 Includes diagnoses in cases whose Aboriginal and Torres Strait Islander status was not reported.
4 Jurisdictions in which Aboriginal and Torres Strait Island status was reported for less than 50% of  diagnoses
Source: State/Territory health authorities; National Notifiable Diseases Surveillance System
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Main Findings
Chlamydia
• Chlamydia continued to be the most frequently reported notifiable condition in Australia in 2013. There 
were a total of  82 537 notifications in 2013, 6 629 (8%) were among the Aboriginal and Torres Strait 
Islander population, 34 344 (41%) were among the non-Indigenous population and Indigenous status 
was not reported for 41 564 (51%) notifications.
• The chlamydia notification rate for the Aboriginal and Torres Strait Islander population of  1 207 per 
100 000 was 3 times that of  the non-Indigenous notification rate at 379 per 100 000 population.
• The chlamydia notification rate in Australia in both the Aboriginal and Torres Strait Islander population 
has plateaued since 2010, with variation by jurisdiction - increasing in Northern Territory and South 
Australia in 2013, and declining in Queensland and Western Australia since 2011.
• Most notifications of  chlamydia diagnoses are among young people. In 2013, 81% of  notifications 
were in 15 – 29 year olds among both the Aboriginal and Torres Strait Islander population and 
non-Indigenous population.
• In major cities, the chlamydia notification rate in the Aboriginal and Torres Strait Islander population 
was 2 times higher than that among the non-Indigenous population, 2 times higher in inner regional 
areas, 5 times higher in outer regional areas, 6 times higher in remote areas, and 4 times higher in very 
remote areas.
Chlamydia continues to be the most frequently reported notifiable condition in Australia in 2013. There were a 
total of  82 537 chlamydia notifications in 2013; of  these 6 629 (8%) were among the Aboriginal and Torres Strait 
Islander population, 34 344 (41%) were among the non-Indigenous population and Indigenous status was not 
reported for 41 564 (51%) cases.
In the period 2009 – 2013, Aboriginal and Torres Strait Islander status was not reported for more than 50% of  
notifications each year in the Australian Capital Territory, New South Wales, and Victoria and as such notification 
data for chlamydia excludes these jurisdictions. Hereinafter notification data for the period 2009 – 2013 refers to 
notification data from the Northern Territory, Queensland, South Australia, Tasmania and Western Australia.
The age-standardised chlamydia notification rate for the Aboriginal and Torres Strait Islander population in 
2013 of  1 207 per 100 000 population was 3 times that of  the non-Indigenous population at 379 per 100 000 
population (Figure 4). Since 2010, the notification rate of  chlamydia in the Aboriginal and Torres Strait Islander 
population and non-Indigenous population has plateaued (Figure 4).
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Figure 4 Notation rates of chlamydia infection by Aboriginal and Torres Strait Islander status1 and year
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Chlamydia diagnoses are notified predominantly among young people. In 2013, 81% of  diagnoses were in 
15 – 29 year olds in both Aboriginal and Torres Strait Islander and non-Indigenous populations (Figure 5). In 2013, 
2 329 and 4 300 chlamydia notifications were among Aboriginal and Torres Strait Islander males and females 
respectively, providing a male to female ratio of  0.5:1 compared to 0.7:1 in the non-Indigenous population.
Figure 5 Number of notifications of chlamydia infections in 2013 by Aboriginal and Torres Strait Islander 
status1, sex and age group
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The chlamydia notification rate in the Aboriginal and Torres Strait Islander population in the 15 – 19 and the 20 – 29 
year age groups in 2013 was more than 4 times and 3 times higher respectively, than in the non-Indigenous 
population (Figure 6, 7). In these age groups, the highest rates were in Aboriginal and Torres Strait Islander 
females, whereas the greatest difference was in 15 – 19 year old males where notification rates in the Aboriginal 
and Torres Strait Islander population were 6 times higher than the non-Indigenous population (Figure 6,7).
The higher notification rates in Aboriginal and Torres Strait Islander females aged 15 – 19 and 20 – 29 years may 
reflect a greater disease burden and/or greater access to health services and subsequent testing in females.
From 2009 – 2013, the chlamydia notification rate in the Aboriginal and Torres Strait Islander population in the 
15 – 19 year and 20 – 29 age group increased between 2009 – 2011, but then declined between 2011 – 2013 
(Figure 7).
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In the non-Indigenous population a similar trend was observed in the 15 – 19 year age group, but in the 20 – 29 
year age group the rate increased steadily from 2009 – 2013 (Figure 7).
Figure 6 Notification rates of chlamydia infection in 2013 by Aboriginal and Torres Strait Islander status1, 
sex and age group
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Figure 7 Notification rates of chlamydia infection in selected age groups Aboriginal and Torres Strait 
Islander status1 and year
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The age-standardised chlamydia notification rate from 2009 – 2013 in the Aboriginal and Torres Strait 
Islander population increased in all jurisdictions from 2009 – 2010 but diverged thereafter; increasing in the 
Northern Territory, South Australia and Tasmania, and decreasing in Queensland and Western Australia. In the 
non-Indigenous population the chlamydia notification rate has increased in all jurisdictions from 2009 – 2013. 
The increase in the Northern Territory was most likely due to a large increase in testing.
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Figure 8 Notification rates of chlamydia infection by Aboriginal and Torres Strait Islander status, State/
Territory1 and year
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In 2013, the chlamydia notification rate in the Aboriginal and Torres Strait Islander population resident in major 
cities (840 per 100 000) was 2 times higher than the rate (367 per 100 000) in the non-Indigenous population; 2 
times higher in inner regional centres; 5 times higher in outer regional areas; 6 times higher in remote areas and 
4 times higher in very remote areas (Figure 9).
Figure 9 Notification rates of chlamydia infection in 2013 by Aboriginal and Torres Strait Islander status1 
and area of residence
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Donovanosis
• Since 2007 there have been fewer than 3 notifications of  donovanosis per year nationally, with zero 
in 2011, one in 2012 and zero in 2013. The National Donovanosis Eradication (Elimination) Project 
was implemented in 2001 - 2004, following the introduction of  improved methods of  diagnosis 
and treatment of  donovanosis. The project was carried out employing strategies such as targeted 
surveillance, high quality education and support of  primary health care workers in their management 
of  genital ulcerative disease, intermittent or short course oral medication and new laboratory 
techniques, for the elimination of  donovanosis.
The decline in the annual number of  notifications of  donovanosis from 13 in 2005 to zero in 2013 may be 
attributed to improved case ascertainment and treatment (Figure 10). There were no notifications of  donovanosis 
in New South Wales, South Australia, Tasmania, Victoria and the Northern Territory in the past 5 years, and 
no notifications in Queensland in the past 3 years. In Western Australia there were no notifications between 
2006 – 2011, with one in 2012 and none in 2013.
Figure 10 Number of notifications of newly diagnosed donovanosis infections by year
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Gonorrhoea
• There were a total of  14 910 notifications of  gonorrhoea in Australia in 2013; 4 052(27%) were 
among the Aboriginal and Torres Strait Islander population, 6 853 (45%) among the non-Indigenous 
population and Indigenous status was not reported for 4 197 (28%) diagnoses.
• In 2013, the gonorrhoea notification rate in the Aboriginal and Torres Strait Islander population was 
14 times that of  the non-Indigenous population (694 vs. 48 per 100 000 population).
• In 2013, 73% of  cases among Aboriginal and Torres Strait Islander population were diagnosed among 
people in the age group 15 – 29 years compared with 52% in the non-Indigenous population.
• The male to female ratio of  gonorrhoea notifications in 2013 in the Aboriginal and Torres Strait Islander 
population was 0.8:1 suggesting transmission predominantly through heterosexual contact. In contrast 
the male to female ratio of  4:1 in the non-Indigenous population suggests transmission occurring 
predominantly through sex between males.
• In 2013, gonorrhoea notification rates in the Aboriginal and Torres Strait Islander population were 
substantially higher than in the non-Indigenous population in all areas of  residence, especially in outer 
regional, remote and very remote areas of  Australia.
Of 14 910 gonorrhoea notifications in 2013; 6 853 (45%) were in the non-Indigenous population, 4 052(27%) in the 
Aboriginal and Torres Strait Islander population and Indigenous status was not reported for 4197 (28%) notifications.
In the period 2009 – 2013, Aboriginal and Torres Strait Islander status was not reported for more than 50% of  
notifications per year in New South Wales, and as such notification data for gonorrhoea excludes this jurisdiction. 
Hereinafter notification data for the period 2009 – 2013 refers to data notified from the Northern Territory, 
Queensland, South Australia, Tasmania, Victoria, the Australian Capital Territory and Western Australia.
Differences in age at diagnoses exist between the Aboriginal and Torres Strait islander population and the 
non-Indigenous population. In 2013, 73% of  gonorrhoea notifications among the Aboriginal and Torres Strait 
Islander population were in 15 – 29 year olds and 33% in 15 – 19 year olds, compared with 52% and 8% in the 
respective age groups in the non-Indigenous population (Figure 11).
In 2013, 1 841 and 2 211 notifications of  gonorrhoea were made among Aboriginal and Torres Strait Islander 
males and females respectively, giving a male to female ratio of  0.8:1 suggesting transmission predominantly 
through heterosexual contact (Figure 11). In comparison, there were 5 150 notifications of  gonorrhoea in males 
and 1 433 in females in the non-Indigenous population in 2013; giving a male to female ratio of  4:1, suggesting 
transmission occurring predominantly by sex between males (Figure 11).
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Figure 11 Number of notifications of newly diagnosed gonorrhoea infections by Aboriginal and Torres 
Strait Islander status1, sex and age group, 2013
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In the age groups 15 – 19 and 20 – 29 years, the gonorrhoea notification rate was 37 and 10 times higher 
respectively among the Aboriginal and Torres Strait Islander population than the non-Indigenous population 
(Figure 12).
Figure 12 Notification rates of gonorrhoea infection in 2013 by Aboriginal and Torres Strait Islander status1, 
sex and age group
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The gonorrhoea notification rate in the Aboriginal and Torres Strait Islander population increased from 589 
per 100 000 in 2009 to 778 per 100 000 in 2011, and then decreased to 694 per 100 000 in 2013. In the 
non-Indigenous population the gonorrhoea notification rate increased steadily by 100% from 24 per 100 000 
to 48 per 100 000 in the period 2009 – 2013 (Figure 15), with similar increases in non-Indigenous males (38 
per 100 000 in 2009 to 77 per 100 000 in 2013) and non-Indigenous females (10 per 100 000 In 2004 to 19 per 
100 000 in 2013).
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Figure 13 Notification rates of gonorrhoea infection in 2013 by Aboriginal and Torres Strait Islander status1 
and year
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From 2009 – 2013, the gonorrhoea notification rate in the Aboriginal and Torres Strait Islander population 
increased by 9% in the 15 – 19 year age group and by 5% in the 20 – 29 year age group (peaking in 2011 and 
declining thereafter), whereas in the non-Indigenous population the rate increased steadily by 43% and 100% in 
respective age groups (Figure 14).
The increase in gonorrhoea notifications in the non-indigenous population may be influenced by the move toward 
routine duplex testing for both chlamydia and gonorrhoea even when chlamydia has only been requested, 
resulting in large and increasing numbers of  low risk people being tested for gonorrhoea, and an increasing 
potential for false positive gonorrhoea tests. Recent trends in gonorrhoea notifications in the non-Indigenous 
population and comparisons made to the Aboriginal and Torres Strait Islander population should therefore be 
interpreted with caution.
Figure 14 Notification rates of gonorrhoea infection in selected age groups by Aboriginal and Torres Strait 
Islander status1 and year
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From 2009 – 2013, the age-standardised gonorrhoea notification rate in the Aboriginal and Torres Strait Islander 
population fluctuated within jurisdictions; with rates in Queensland and Western Australia peaking in 2011 and 
then declining, and in the Northern Territory and South Australia peaking in 2010 and fluctuating thereafter 
(Figure 15).
Figure 15 Notification rates of gonorrhoea infection by Aboriginal and Torres Strait Islander status, State/
Territory1 and year
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In 2013, in the Aboriginal and Torres Strait Islander population resident in major cities, inner regional, outer 
regional, remote and very remote areas, the population rate of  gonorrhoea was 4 times, 3 times, 27 times, 54 
times, and 26 times higher than the rate in the non-Indigenous population, respectively (Figure 16).
Figure 16 Notification rates of gonorrhoea infection in 2013 by Aboriginal and Torres Strait Islander status1 
and area of residence
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Infectious syphilis
• Notifications of  infectious syphilis have been reported nationally since 2004.
• There were a total of  1 764 infectious syphilis notifications nationally in 2013, with 142 (8%) among the 
Aboriginal and Torres Strait Islander population, 1 457 (83%) among the non-Indigenous population 
and a further 165 (9%) cases for which Indigenous status was not reported.
• In 2013, the infectious syphilis notification rate in the Aboriginal and Torres Strait Islander population 
was close to 3 times higher than the non-Indigenous population (18 vs. 7 per 100 000 population).
• The infectious syphilis notification rate in the Aboriginal and Torres Strait Islander population increased 
in 2010, particularly in Queensland and among 15 – 19 year olds, attributed to an outbreak of  
syphilis in some Queensland remote communities. In 2011 – 2013, notifications of  infectious syphilis 
decreased in Aboriginal and Torres Strait Islander communities. However the trend varies across 
jurisdictions; with a substantial decline in the Northern Territory since 2010 and a decline in Western 
Australia and South Australia since 2011, and Queensland since 2012.
• The number of  infectious syphilis notifications among Aboriginal and Torres Strait Islander males 
and females in 2013 was 74 and 68 (male to female ratio of  1.1:1) respectively, whereas in the 
non-Indigenous population there were 1 531 notifications in males and 79 in females in 2013 (male 
to female ratio of  19:1). This suggests transmission occurs predominantly through heterosexual 
contact in the Aboriginal and Torres Strait Islander population, and through sex between males in the 
non-Indigenous population.
• In 2013, 82% and 53% of  infectious syphilis notifications in the Aboriginal and Torres Strait Islander 
and non-Indigenous populations respectively occurred among people aged less than 40 years of  age.
• In 2013, the infectious syphilis notification rate among Aboriginal and Torres Strait Islander population 
increased as remoteness of  residence increased, whereas in the non-Indigenous population the rate 
was highest in major cities and inner regional areas.
Accurate and complete systems for the notification of  infectious syphilis exist nationally, enabling greater than 
91% of  all infectious syphilis diagnoses to be notified by Aboriginal and Torres Strait Islander status.
In 2013, there were 1 764 infectious syphilis notifications nationally, with 142 (8%) cases among the Aboriginal 
and Torres Strait Islander population, 1 457 cases (83%) among the non-Indigenous population and a further 
165 cases (9%) for which Indigenous status was not reported.
In 2013, 52% of  notifications of  infectious syphilis in the Aboriginal and Torres Strait Islander population were 
among males, compared with 94% in the non-Indigenous population (Figure 17). The male to female ratio 
among the Aboriginal and Torres Strait Islander cases indicates transmission of  infectious syphilis predominantly 
through heterosexual contact and through sex between males in the non-Indigenous population.
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Figure 17 Number of notifications of newly diagnosed infectious syphilis in 2013 by Aboriginal and Torres 
Strait Islander status1, sex and age group
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In 2013, the age-standardised infectious syphilis notification rate in the Aboriginal and Torres Strait Islander 
population was nearly 3 times that of  the non-Indigenous population (18 vs. 7 per 100 000 population) (Figure 18).
In the Aboriginal and Torres Strait Islander population the number of  infectious syphilis notifications increased 
from 122 cases in 2009 to 204 in 2011, and then decreased to 173 in 2012 and 142 in 2012.
Figure 18 Notification rates of infectious syphilis by Aboriginal and Torres Strait Islander status1 and year
0
5
10
15
20
25
30
35
20132012201120102009
YEAR
AG
E 
ST
AN
DA
RD
IS
ED
 R
AT
E 
PE
R 
10
0 
00
0
Aboriginal and Torres Strait Islander Non-Indigenous
1 Jurisdictions (NSW, NT, QLD, SA, TAS, VIC, ACT & WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
In 2013, the infectious syphilis notification rate was highest in the 15 – 19 year age groups for Aboriginal and 
Torres Strait Islander population, and 30 – 39 years for the non-Indigenous population (Figure 19).
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Figure 19 Notification rates of infectious syphilis in 2013 by Aboriginal and Torres Strait Islander status1, 
sex and age group
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Figure 20 Notification rates of infectious syphilis in selected age groups in 2013 by Aboriginal and Torres 
Strait Islander status1
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In 2013, the majority of  142 infectious syphilis notifications in the Aboriginal and Torres Strait Islander population 
occurred in Queensland (65%), New South Wales (11%), Northern Territory (8%), Western Australia (6%), 
South Australia (5%) and Victoria (4%)  In contrast the majority of  1 622 infectious syphilis notifications in the 
non-Indigenous population occurred in Victoria (40%), New South Wales (38%) and Queensland (15%).
From 2009 – 2013, the age-standardised notification rate of  infectious syphilis in the Aboriginal and Torres Strait 
Islander population decreased steadily by 79% in the Northern Territory (62 in 2009 to 13 per 100 000 in 2013), by 
73% in Western Australia (32 in 2009 to 9 per 100 000 in 2013) but increased by 126% in Queensland, particularly 
between 2009 – 2011 (16 in 2009 to 50 per 100 000 In 2011), and declined in 2012 – 2013 at 36 per 100 000 
(Figure 21).
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Figure 21 Notification rates of infectious syphilis by Aboriginal and Torres Strait Islander status, State/
Territory1 and year
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In 2013, the infectious syphilis notification rate in the Aboriginal and Torres Strait Islander population was similar 
to that of  the non-Indigenous population in major cities (7.4 versus 7.7 per 100 000) but 2 times higher in inner 
regional areas, increasing to 12, 16 and 31 times the rate in outer regional, remote and very remote areas of  
Australia, respectively (Figure 22).
Figure 22 Notification rates of infectious syphilis in 2013 by Aboriginal and Torres Strait Islander status1 
and area of residence
0
10
20
30
40
50
60
70
80
90
100
Very remoteRemoteOuter regionalInner regional Major cities
AREA OF RESIDENCE
Aboriginal and Torres Strait Islander Non-Indigenous
RA
TE
 P
ER
 1
00
 0
00
1 Jurisdictions (NSW, NT, QLD, SA, TAS, VIC, ACT and WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
28 Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
Bacterial STIs reported in persons aged less than 16 years
The occurrence of  STIs among the Aboriginal and Torres Strait Islander population aged less than 16 years 
linked to child sexual assault is a sensitive issue and often unnecessarily linked. The occurrence of  chlamydia, 
gonorrhoea and infectious syphilis among people aged 15 years or younger is described, based on cases 
notified to the National Notifiable Diseases Surveillance System and is summarised only for those jurisdictions in 
which Aboriginal and Torres Strait Islander status was reported for at least 50% of  notifications in each year over 
the past five years.
From 2009 – 2013, a total of  3 320 and 3 455 cases of  chlamydia were reported among Aboriginal and Torres 
Strait Islander and the non-Indigenous populations aged less than 16 years respectively. In the same period 
1 892 and 204 cases of  gonorrhoea and 54 and 6 cases of  infectious syphilis were reported in the Aboriginal 
and Torres Strait Islander and non-Indigenous populations aged less than 16 years respectively. Within the 
Aboriginal and Torres Strait Island population, the majority of  these notifications (95% for chlamydia, 94% for 
gonorrhoea and 94% for infectious syphilis) were among people aged 13 to 15 years. A similar pattern of  
diagnosis occurred among the non-Indigenous young population where 97% of  chlamydia, 92% of  gonorrhoea 
and 67% of  infectious syphilis notifications were among people aged 13 to 15 years. The majority of  diagnoses 
of  STIs in the young Aboriginal and Torres Strait Islander population occurred in areas of  known high endemicity 
of  STIs, and where screening for STIs is routinely carried out. Caution should be taken in describing these data 
as related to child sexual assault; as it is likely that a significant proportion of  these notifications are the result of  
early sexual debut and/or sex with peer-aged partners.
29Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
HIV infection
• A total of  1 236 notifications of  newly diagnosed HIV infection were reported in 2013 including 26 
which were identified as Aboriginal and Torres Strait Islander. In 2013, the notification rate of  newly 
diagnosed HIV infection was higher for the Aboriginal and Torres Strait Islander population (4.9 per 
100 000) compared to the non-Indigenous population (3.9 per 100 000).
• During the period 2004 – 2013, 231 notifications of  newly diagnosed HIV infections were among the 
Aboriginal and Torres Strait Islander population; 79% were among males, the median age at diagnosis 
was 33 years, 28% of  cases were classified as newly acquired cases, and 33% were classified as a 
delayed HIV diagnosis (CD4+ cell count of  <350 cells/µl).
• In the period 2009 – 2013, a higher proportion of  notifications of  newly diagnosed HIV infection 
among the Aboriginal and Torres Strait Islander population were attributed to injecting drug use (12% 
vs. 3%) and heterosexual contact (21% vs. 13%) and in females (20% vs 5%), as compared with the 
non-Indigenous Australian-born population.
All jurisdictions report accurate and complete data sets for newly diagnosed HIV infection. Accurate and 
complete systems for the notification of  newly diagnosed HIV infection exist nationally which enables greater 
than 99% of  all newly diagnosed HIV infections to be notified by Aboriginal and Torres Strait Islander status.
In 2013, of  the 1 236 notifications of  newly diagnosed HIV infections, 1 210 were identified as non-Indigenous 
and 26 as Aboriginal and Torres Strait Islander. The age-standardised notification rate of  newly diagnosed HIV 
infection was higher in the Aboriginal and Torres Strait Islander population (4.9 per 100 000) than that of  the 
non-Indigenous population (3.9 per 100 000) (Figure 23).
Figure 23 Notification rates of newly diagnosed HIV infection in the Australian‑born population, by 
Aboriginal and Torres Strait Islander status1 and year
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Of  the 231 notifications of  newly diagnosed HIV infections among the Aboriginal and Torres Strait Islander 
population in the 10 year period 2004 – 2013, 79% were diagnosed among males, the median age at diagnosis 
was 33 years, 28% of  cases were classified as newly acquired cases and 33% were classified as a delayed HIV 
diagnosis (CD4+ cell count of  <350 cells/µl) (Table 3)
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National surveillance for newly diagnosed HIV infection in Aboriginal and Torres Strait 
Islander people
Table 3 Characteristics of cases of newly diagnosed HIV infection in Aboriginal and Torres Strait 
Islander people, 2004 – 2013, by year. Number of cases, median age and percent (number) of 
total cases by sex, newly acquired infection, HIV status at diagnosis, State/Territory and HIV 
exposure category
Year of HIV diagnosis
Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total1,2
Total cases 22 20 23 19 19 24 22 23 33 26 231
Males (%) 72.7 85.0 73.9 84.2 79.0 83.3 68.2 73.9 81.8 84.6 78.8
Median age (years) 29 33 31 33 36 37 35 33 27 37 33
Newly acquired 
HIV infection (%)1 31.8 (7) 15.0 (3) 30.4 (7) 26.3 (5) 31.6 (6) 29.2 (7) 22.7 (5) 21.7 (5) 30.3 (10) 34.6 (9) 27.7 (64)
Late and advanced HIV infection status at HIV diagnosis(%)2,3 
Late HIV diagnosis 4.5 5.0 13.0 26.3 21.1 12.5 18.2 4.3 9.1 15.4 12.6
Advanced HIV infection 31.8 10.0 8.7 10.5 15.8 33.3 9.1 34.8 21.2 26.9 20.8
State/Territory (%)
Australian Capital Territory 0 0 0 0 0 0 0 0 0 0 0
New South Wales 4 3 9 8 8 9 7 5 11 8 72
Northern Territory 1 0 0 0 1 0 1 2 2 1 8
Queensland 5 9 6 5 2 8 8 8 14 9 74
South Australia 2 0 0 1 4 2 1 1 1 2 14
Tasmania 1 0 0 0 0 1 0 1 0 1 4
Victoria 4 2 2 3 0 1 3 1 5 5 26
Western Australia 5 6 6 2 4 3 2 5 0 0 33
HIV exposure category (%)4 
Men who have sex with men 52.4 (11) 35.0 (7) 47.8 (11) 47.4 (9) 47.4 (9) 52.6 (10) 60.0 (12) 63.6 (14) 71.9 (23) 24.0 (6) 50.9 (112)
Men who have sex with men, 
and injecting drug use 0.0 (0) 25.0 (5) 4.3 (1) 15.8 (3) 5.3 (1) 15.8 (3) 5.0 (1) 0.0 (0) 3.1 (1) 20.0 (5) 9.1 (20)
Injecting drug use5 19.0 (4) 15.0 (3) 21.7 (5) 15.8 (3) 36.8 (7) 10.5 (2) 20.0 (4) 4.5 (1) 6.3 (2) 24.0 (6) 16.8 (37)
Heterosexual contact 28.6 (6) 25.0 (5) 26.1 (6) 21.1 (4) 10.5 (2) 21.1 (4) 15.0 (3) 27.3 (6) 18.8 (6) 32.0 (8) 22.7 (50)
Haemophilia/coagulation 
disorder 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0)
Receipt of blood/tissue 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0)
Mother with/at risk of HIV 
infection 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 4.5 (1) 0.0 (0) 0.0 (0) 0.5 (1)
Health care setting 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0)
Other/undermined exposure 4.5 (1) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 20.8 (5) 9.1 (2) 4.3 (1) 3.0 (1) 3.8 (1) 4.8 (11)
1. Newly acquired HIV infection was defined as newly diagnosed infection with a negative or indeterminate HIV antibody test result or a diagnosis of primary HIV infection 
within one year of HIV diagnosis. 
2. Late diagnosis and advanced infection for HIV diagnoses in 2004 only. Total percentage with late HIV diagnosis and advanced HIV infection in 2004 – 2013 only.
3. Late HIV diagnosis was defined as newly diagnosed HIV infection with a CD4+ cell count of 200 or more to less than 350 cells/µl, and advanced HIV infection as newly 
diagnosed infection with a CD4+ cell count of less than 200 cells/µl.
4. The “Other/undetermined” exposure category was excluded from the calculation of the percentage of cases attributed to each HIV exposure category.
5. Excludes men who have sex with men.
Source: State/Territory health authorities
31Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
For the purposes of  a longer term trend analysis of  HIV diagnosis in the Aboriginal and Torres Strait Islander 
population we have analysed data for the period 2004 – 2013 and compared this to data for the non-Indigenous 
Australian-born population.
In 2004 – 2013, the age-standardised notification rate of  newly diagnosed HIV infection in the Aboriginal and 
Torres Strait Islander population was 3.9 per 100 000 in 2004, rates then fluctuated until 2011 and then increased 
in 2012 – 2013, reaching 4.9 per 100 000 in 2013. In the non-Indigenous Australian-born population, the rate 
remained stable; 3.7 per 100 000 in 2004 and 3.9 per 100 000 in 2013. The notification rates of  newly diagnosed 
HIV infection in the Aboriginal and Torres Strait Islander population are based on small numbers, and may reflect 
localised occurrences rather than national patterns.
For males, the notification rate of  newly diagnosed HIV infection in the Aboriginal and Torres Strait Islander 
population fluctuated, with a decline in 2010 and an increase in 2012 – 2013 (6.0 in 2004, 4.1 in 2010 and 8.7 per 
100 000 in 2013) and non-Indigenous Australian-born males (7.0 in 2004 to 7.5 in 2013 per 100 000) (Figure 24).
The notification rate of  newly diagnosed HIV infection among Aboriginal and Torres Strait Islander females 
fluctuated between 1.8 per 100 000 population in 2004 to 1.3 per 100 000 population in 2013, but were higher 
than non-Indigenous Australian-born females where the rate of  HIV diagnosis remained stable (0.4 in 2004 and 
0.4 per 100 000 in 2013) (Figure 24).
Figure 24 Notification rates of newly diagnosed HIV infection in the Australian‑born population, by 
Aboriginal and Torres Strait Islander status1, sex and year
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In the period 2009 – 2013, a higher proportion of  notifications of  newly diagnosed HIV infection among the 
Aboriginal and Torres Strait Islander population were attributed to injecting drug use (12% vs. 3% respectively) 
and a similar proportion to heterosexual contact (21% vs. 13% respectively) and in females (20% vs 5%) as 
compared with the non-Indigenous Australian only population (Figure 25).
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Figure 25 Notification rates of newly diagnosed HIV infection in the Australian‑born population, by 
Aboriginal and Torres Strait Islander status1 and HIV exposure category
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1 Jurisdictions (NSW, NT, QLD, SA, TAS, VIC, ACT & WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
During the period 2009 – 2013, notifications of  newly diagnosed HIV infection among the Aboriginal and Torres 
Strait Islander population were reported from Queensland (37%), New South Wales (31%), Victoria (12%) and 
Western Australia (8%) (Table 3).
In 2013, the notification rate of  newly diagnosed HIV infection was highest among those resident in major cities 
in both the Aboriginal and Torres Strait Islander population and the non-Indigenous population (Figure 26). The 
rate of  HIV diagnosis in the Aboriginal and Torres Strait Islander population was 6 per 100 000 in major cities, 
compared to 0 per 100 000 in remote areas. The rate of  HIV diagnosis in the non-Indigenous population was 6 
per 100 000 in major cities compared to 3 per 100 000 in the remote areas (Figure 26 and Table 4).
Figure 26 Notification rates of newly diagnosed HIV infection in 2013 in the Australian‑born population, 
by Aboriginal and Torres Strait Islander status and area of residence
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Table 4 Rate of diagnosis of HIV infection1, 2009 – 2013, by area of residence, Aboriginal and Torres 
Strait Islander status and year
Year of diagnosis
Area of residence Aboriginal and Torres Strait Islander status 2009 2010 2011 2012 2013
Major cities Aboriginal and Torres Strait Islander 8 6 5 9 6
non-Indigenous2 6 6 6 6 6
Inner regional Aboriginal and Torres Strait Islander 1 2 2 4 2
non-Indigenous2 2 2 2 2 2
Outer regional Aboriginal and Torres Strait Islander 2 3 3 3 5
non-Indigenous2 3 3 3 4 4
Remote Aboriginal and Torres Strait Islander 0 2 0 2 2
non-Indigenous2 2 1 1 3 3
Very remote Aboriginal and Torres Strait Islander 2 1 4 0 1
non-Indigenous2 4 3 2 9 4
Total Aboriginal and Torres Strait Islander 4 3 3 5 4
non-Indigenous2 5 5 5 6 5
In the Oceania region, Australia is among the countries with the lowest prevalence of  HIV infection in its 
population aged 15 - 49 years. Australia’s nearest neighbour, Papua New Guinea, has the highest HIV 
prevalence in its population aged 15 - 49 years. It is important to view this data in the context of  family and 
cultural connections between some Torres Strait Islander communities and Papua New Guinea population 
(Figure 27 and Table 5)
Figure 27 HIV prevalence in selected countries
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Global comparisons
Table 5 Estimated HIV prevalence in selected countries
HIV prevalence
Country 20131 Rate2
Africa
Mauritius3 9 635  743
Somalia3 32 313  308
South Africa3 6 274 091 11 842
Sudan South3 153 108 1 355
Zambia3 1 110 409 7 638
Zimbabwe3 1 390 293 9 826
Asia Pacific
Australia 26 800  116
Cambodia3 75 248  497
China4 780 000 <100
Indonesia3 641 359  257
Japan4 7 900 <100
Malaysia3 86 324  290
Myanmar3 192 465  361
New Zealand5 2 600 <100
Papua New Guinea3 31 945  436
Philippines5 15 000 <100
Republic of Korea3 15 000 <100
Thailand3 435 284  650
Vietnam3 248 646  277
Europe
France5 160 000  400
Germany6 77 513 <100
Italy3 122 018  204
Spain3 150 424  322
United Kingdom3 126 660  198
North America
Canada3 71 000  300
United States7 1 144 500  406
1 Estimated number of people living with HIV/AIDS.
2 Rate per 100 000 population.
3 Estimated HIV prevalence in people in all age in 2013.
4 Estimated HIV prevalence in people in all age in 2011.
5 Estimated HIV prevalence in people aged 15 – 49 years in 2011.
6 Estimated HIV prevalence in people in all age in 2012.
7 Estimated HIV prevalence for people aged ≥13 in 2010.
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HBV
Newly diagnosed HBV Infection
• There were a total of  7 151 notifications of  newly diagnosed HBV infection in Australia in 2013; 
of  these 206 (3%) were among the Aboriginal and Torres Strait Islander population, 2 693 (38%) 
were among the non-Indigenous population and a further 4 252 (59%) notifications for which 
Indigenous status was not reported.
• In 2013, the notification rate of  newly diagnosed HBV infection for the Aboriginal and Torres Strait 
Islander population was close to 2 times higher than the non-Indigenous population  
(72 per 100 000 versus 32 per 100 000).
• In the period 2009 – 2013, there was a 28% decline in the notification rate of  newly diagnosed 
HBV infection in the Aboriginal and Torres Strait Islander population (from 100 per 100 000 in 2009 
to 72 per 100 000 in 2013), with a 10% increase in rates in the non-Indigenous population  
(from 29 per 100 000 in 2009 to 32 per 100 000 In 2013).
• Aboriginal and Torres Strait Islander aged 30 – 49 years experienced substantially higher rates of  
newly diagnosed HBV infection compared to other age groups.
Newly acquired HBV infections
• There were 172 newly acquired HBV infections notified in 2013; 13 (8%) were among the 
Aboriginal and Torres Strait Islander population, 130 (76%) were among the non-Indigenous 
population and a further 29 (17%) notifications for which Indigenous status was not reported.
• In 2013, the notification rate of  newly acquired HBV infection for the Aboriginal and Torres Strait 
Islander and non-Indigenous populations were 1.9 and 0.7 per 100 000, respectively.
• In the period 2009 – 2013, the notification rate of  newly acquired HBV infection remained stable in 
the Aboriginal and Torres Strait Islander and non-Indigenous populations.
• In 2013, 69% and 95% of  notifications of  newly acquired HBV infection in the Aboriginal and 
Torres Strait Islander and non-Indigenous populations respectively, were in those aged 20 years 
of  age and over.
Newly diagnosed HBV infections
This section focuses on newly diagnosed HBV infection which means that a person previously not known to have 
the infection has been tested and now found to have the infection. These diagnoses include newly acquired 
infections (previous negative test in the past 2 years) plus those with a previous test more than 2 years or the 
time period is unknown.
There were a total of  7 151 notifications of  newly diagnosed HBV infection in Australia in 2013; of  these 206 (3%) 
were among the Aboriginal and Torres Strait Islander population, 2 693 (38%) were among the non-Indigenous 
population and a further 4 252 (59%) were notifications for which Indigenous status was not reported.
In the period 2009 – 2013, Aboriginal and Torres Strait Islander status was reported in less than 50% of  notifications 
per year in New South Wales, Queensland and Victoria and as such notification data for newly diagnosed HBV 
excludes these jurisdictions. Hereinafter notification data for the period 2009 – 2013 refers to data notified from the 
Northern Territory, South Australia, Tasmania, the Australian Capital Territory and Western Australia.
In 2013, the age-standardised notification rate of  newly diagnosed HBV infection for the Aboriginal and Torres 
Strait Islander population was close to 2 times higher than the non-Indigenous population (72 per 100 000 versus 
32 per 100 000) (Figure 28).
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In the period 2009 – 2013, there was a decline in the notification rates of  newly diagnosed HBV infection In the 
Aboriginal and Torres Strait Islander population (from 100 per 100 000 in 2009 to 72 per 100 000 in 2013), with 
rates remaining steady in the non-Indigenous population (Figure 28).
Figure 28 Notification rates of newly diagnosed HBV infection by Aboriginal and Torres Strait Islander 
status1 and year
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In 2013, Aboriginal and Torres Strait Islander people aged 30 – 49 years experienced substantially higher rates 
of  newly diagnosed HBV infection than other age groups (Figure 29).
Figure 29 Notification rates of newly diagnosed HBV infection by Aboriginal and Torres Strait Islander 
status1, age and year
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Newly acquired HBV infection
This section focuses on newly acquired HBV infection which means that a person previously known not to have 
the infection within the last two years has been tested and now found to have the infection 
Information on Aboriginal and Torres Strait Islander status was reported for more than 50% of  notifications of  
newly acquired HBV infection in all jurisdictions.
In 2013, 13 notifications of  newly acquired HBV infection were diagnosed in the Aboriginal and Torres Strait 
Islander population and 130 in the non-Indigenous population.
In the period 2009 – 2013 the age-standardised notification rate of  newly acquired HBV infection in the 
Aboriginal and Torres Strait Islander population remained stable at around 2 per 100 000 and also remained 
stable at around 1 per 100 000 in the non-Indigenous population over the same time period (Figure 30).
Figure 30 Notification rates of newly acquired HBV infection by Aboriginal and Torres Strait Islander status1 
and year
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In 2013, the majority of  notifications of  newly acquired HBV infection in both the Aboriginal and Torres Strait 
Islander (69%) and the non-Indigenous population (95%) occurred in people aged over 20 years. In 2013, the 
male to female ratio of  newly acquired HBV infection in the Aboriginal and Torres Strait islander population was 
1.2:1 compared with 3.7:1 in the non-Indigenous population (Figure 31).
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Figure 31 Number of notifications of newly acquired HBV infection in 2013, by Aboriginal and Torres Strait 
Islander
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In 2013, the notification rate of  newly acquired HBV infection in the Aboriginal and Torres Strait Islander 
population was higher in all age groups than the rates in non-Indigenous population (Figure 32).
Figure 32 Notification rates of newly acquired HBV infection in 2013, by Aboriginal and Torres Strait 
Islander status1, sex and age group
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The age-standardised notification rate of  newly acquired HBV infection in the Aboriginal and Torres Strait 
Islander population fluctuated over time in individual jurisdictions (Figure 33) and overall within age groups 
(Figure 34).
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Figure 33 Notification rates of newly acquired HBV infection by Aboriginal and Torres Strait Islander status, 
State/Territory1 and year
0
2
4
6
8
10
12
14
20132012201120102009
0
2
4
6
8
10
12
14
20132012201120102009
QLD SAACT NSW TAS WAVICNT
AG
E 
ST
AN
DA
RD
IS
ED
 R
AT
E 
PE
R 
10
0 
00
0
YEAR OF DIAGNOSISYEAR OF DIAGNOSIS
NON-INDIGENOUSABORIGINAL AND TORRES STRAIT ISLANDER
1 Jurisdictions (NSW, ACT, NT, QLD, SA, TAS, VIC & WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
Figure 34 Notification rates of newly acquired HBV infection in selected age groups by Aboriginal and 
Torres Strait Islander status1 and year
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In 2013, the notification rate of  newly acquired HBV infection in the Aboriginal and Torres Strait Islander 
population was similar to that of  the non-Indigenous population in major cities (0.8 versus 0.6 per 100 000) and 
inner regional areas (0.6 and 0.9 per 100 000) respectively, but was 2 times higher in outer regional areas. This 
increased to 7 and 6 times the notification rate as compared with the non-Indigenous population in remote and 
very remote areas of  Australia respectively (Figure 35).
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Figure 35 Notification rates of newly acquired HBV infection in 2013, by Aboriginal and Torres Strait 
Islander status1 and area of residence
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A survey repeated every 4 – 5 years among Australian prison entrants showed that the prevalence of  HBV 
infection was close to 2 times greater than non-Indigenous entrants each survey (4.2% versus 2.7% respectively) 
(Figure 36). Also at the end of  2011, an estimated 20 290 Aboriginal and Torres Strait Islander people were living 
with chronic HBV (3.7% of  the population) compared with 41 531 non-Indigenous Australian-born people (0.3% 
of  the population) (MacLachlan 2013).
The higher rates of  newly diagnosed HBV infections in the Aboriginal and Torres Strait Islander population than 
the non-Indigenous population could reflect historical transmission primarily perinatal or in early childhood, with 
some additional transmission through sex and blood contact in adolescence and adulthood. Aboriginal and 
Torres Strait Islander people also have higher rates of  risk factors for adult HBV acquisition, including through 
injecting (Ward 2011), and incarceration (ABS Prisoners in Australia Report 2012), which may account for 
higher rates of  newly acquired infection. In 2012, imprisonment rates for the Aboriginal and Torres Strait Islander 
population were reported to be 15 times higher than the non-Indigenous population.
The discrepancy in diagnoses rates between the Aboriginal and Torres Strait Islander population and the 
non-Indigenous population may be reduced in the cohort of  universal neonatal vaccines (whom are now aged 
up to 25 years in the Northern Territory, and 15 years elsewhere in the country). However in 2010 – 2012, 
HBV immunisation coverage rates were lower for the Aboriginal and Torres Strait Islander children than 
non-Indigenous for the 12 months age group, with little or no difference at 24 months of  age (Figure 37). The 
lower rates at 12 months suggest issues around timeliness of  completion of  the course in Aboriginal and Torres 
Strait Islander children, which may lead to increased risk of  disease acquisition.
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Figure 36 Hepatitis B and hepatitis C antibody prevalence among a sample of incoming Australian 
prisoners by Aboriginal and Torres Strait Islander status and year
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Figure 37 Hepatitis B vaccination coverage estimates at 12 and 24 months, by Aboriginal and Torres Strait 
Islander status and year
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HCV
Newly diagnosed HCV infections
• A total of  10 715 cases of  newly diagnosed HCV infection were reported in Australia in 2013; 
796 (7%) occurred among the Aboriginal and Torres Strait Islander population, 3 596 (34%) were 
among the non-Indigenous population and a further 6 323 (59%) cases for which Indigenous 
status was not reported.
• The rate of  newly diagnosed HCV infection in the Aboriginal and Torres Strait Islander population 
was 142 per 100 000, 3 times higher than the 41 per 100 000 in the non-Indigenous population.
• There was a 29% increase in the notification rate of  newly diagnosed HCV infection in the 
Aboriginal and Torres Strait Islander population whereas the rate in the non-Indigenous population 
remained steady.
Newly acquired HCV infection
• In 2013, the majority of  notifications of  newly acquired HCV infection among the Aboriginal and 
Torres Strait Islander population and non-Indigenous population were attributed to injecting drug use.
Newly diagnosed HCV infections
This section focuses on newly diagnosed HCV infection which means that a person previously not known to have 
the infection has been tested and now found to have the infection. These diagnoses include newly acquired 
infections (previous negative test in the past 2 years) plus those with a previous test more than 2 years or the 
time period is unknown.
In 2013, there were 796 notifications of  newly diagnosed HCV infection among the Aboriginal and Torres Strait 
Islander population, representing 7% of  all notifications.
In the period 2009 – 2013, Aboriginal and Torres Strait Islander status was reported in less than 50% of  
notifications per year in the Australian Capital Territory, New South Wales, Victoria and Queensland and as such 
notification data for HCV excludes these jurisdictions. Hereinafter notification data for the period 2009 – 2013 
refers to data notified from the Northern Territory, South Australia, Tasmania, and Western Australia.
In the period 2009 – 2013, the age-standardised notification rate of  newly diagnosed HCV infection in the 
Aboriginal and Torres Strait Islander population increased from 110 in 2009 to 142 in 2013, whereas the rate in the 
non-Indigenous population has remained stable at 44 per 100 000 in 2008 and 41 per 100 000 in 2013 (Figure 38).
Figure 38 Notification rates of newly diagnosed hepatitis C infection by Aboriginal and Torres Strait 
Islander status1 and year
0
20
40
60
80
100
120
140
160
20132012201120102009
YEAR
AG
E 
ST
AN
DA
RD
IS
ED
 R
AT
E 
PE
R 
10
0 
00
0
Aboriginal and Torres Strait Islander Non-Indigenous
1 Jurisdictions (NT, SA, TAS & WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
43Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
In 2013, the majority (92%) of  notifications of  newly diagnosed HCV infection in both the Aboriginal and Torres 
Strait Islander and the non-Indigenous population occurred in people aged over 20 years (Figure 39).
Figure 39 Number of notifications of newly diagnosed hepatitis C infection in 2013, by Aboriginal and 
Torres Strait Islander status1, sex and age group
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In the Aboriginal and Torres Strait Islander population aged 15 – 19, 20 – 29, 30 – 39 and 40 – 49 years the 
notification rates of  newly diagnosed HCV infection in 2013 were 6, 5, 4, 4 and 4 times higher than the rates in 
the non-Indigenous population, respectively (Figure 40).
Figure 40 Notification rates of newly diagnosed hepatitis C infection in 2013, by Aboriginal and Torres 
Strait Islander status1, sex and age group
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Between 2009 – 2013, the age-standardised notification rate of  newly diagnosed HCV infection in the Aboriginal 
and Torres Strait Islander population fluctuated in individual jurisdictions, except in Western Australian where 
rates have increased steadily since 2010 (Figure 41).
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Figure 41 Notification rates of newly diagnosed hepatitis C infection by Aboriginal and Torres Strait 
Islander status1, State/Territory and year
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Between 2009 – 2013, notification rates of  newly diagnosed HCV infection in the Aboriginal and Torres Strait 
Islander population aged 20 – 29, 30 – 39 and 40 – 49 years have increased (Figure 42).
Figure 42 Notification rates of newly diagnosed hepatitis C infection by Aboriginal and Torres Strait 
Islander status1 and year
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In 2013, the notification rate of  newly diagnosed HCV infection among the Aboriginal and Torres Strait Islander 
population in major cities, inner regional and outer regional areas was 10, 5 and 3 times higher respectively than 
the rate of  diagnosis in the non-Indigenous population resident in the same areas. Notification rates of  newly 
diagnosed HCV infection were lower in remote areas and very remote areas among the Aboriginal and Torres 
Strait Islander population than the non-Indigenous population, respectively (Figure 43).
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Figure 43 Notification rates of newly diagnosed hepatitis C infection in 2013, by Aboriginal and Torres 
Strait Islander status1 and area of residence
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1 Jurisdictions (NT, SA, TAS and WA) in which Aboriginal and Torres Strait Islander status was reported for more than 50% of  diagnoses
The increase in newly diagnosed HCV infection in the Aboriginal and Torres Strait Islander population could be 
due to increased HCV screening.
Newly acquired HCV infection
This section focuses on newly acquired HCV infection which means that a person previously known not to have 
the infection within the last two years has been tested and now found to have the infection. These data on newly 
acquired infections should be interpreted with caution as they are likely to under-estimate the true number of  
newly acquired infections in the community for a number of  reasons: infections are rarely symptomatic in the 
early stages and most cases will therefore remain undetected. Also, even if  testing is conducted, it may be 
difficult to distinguish a newly diagnosed case as newly acquired unless there is a history of  a recent negative 
test prior to the positive diagnosis
Information on Aboriginal and Torres Strait Islander status was reported for more than 50% of  notifications of  
newly acquired HCV infection in all jurisdictions.
In 2013, 72 notifications of  newly acquired HCV infection were diagnosed in the Aboriginal and Torres Strait 
Islander population and 273 in the non-Indigenous population.
In 2013, the age-standardised notification rate of  newly acquired HCV infection in the Aboriginal and Torres 
Strait Islander population was 6 times that of  the non-Indigenous population (10 versus 1.5 per 100 000 
respectively) (Figure 44).
In 2013, the majority of  notifications of  newly acquired HCV infection among the Aboriginal and Torres Strait 
Islander population (78%) and non-Indigenous population (73%) were attributed to injecting drug use.
In the period 2009 – 2013, the notification rate of  newly acquired HCV infection in the Aboriginal and Torres Strait 
Islander and non-Indigenous populations fluctuated (Figure 44).
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Figure 44 Notification rates of newly acquired hepatitis C infection by Aboriginal and Torres Strait Islander 
status1 and year
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In the Aboriginal and Torres Strait Islander population the highest rate of  newly acquired HCV infection was in 
the 20 – 29 age group.
Figure 45 Notification rate of newly acquired hepatitis C infection by Aboriginal and Torres Strait Islander 
status1, age and year
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The higher rates of  newly diagnosed and newly acquired HCV infection in the Aboriginal and Torres Strait 
Islander population as compared with the non-Indigenous population could be due to greater levels of  HCV 
screening in the Aboriginal and Torres Strait Islander population compared to non-Indigenous and/or reflect a 
greater burden of  disease due to injecting risk behaviour (Ward 2011), and/or higher rates of  incarceration (ABS 
Prisoners in Australia Report 2012).
Data routinely collected from the Australian Needle Syringe Program (NSP) Survey provides an insight into the 
demographics, risk behaviour, and blood-borne virus prevalence among people who inject drugs who attend 
NSPs. In the period from 2009 – 2013, the proportion of  participants identified as Aboriginal and/or Torres Strait 
Islander remained stable at between 11 – 13%. HCV antibody prevalence was slightly higher among Aboriginal 
and Torres Strait Islander survey respondents compared to non-Indigenous participants for all years, except 
for 2010 (Figure 46). In 2013, HCV antibody prevalence was 62% among Aboriginal and Torres Strait Islander 
47Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2014
participants compared with 52% of  non-Indigenous participants (Figure 46). In 2013, HIV prevalence remained 
low at 1.3% in the Aboriginal and Torres Strait Islander population, and 2.1% in the non-Indigenous population.
In addition, a study comparing 16,132 unique individuals attending Australian NSPs from 1998 to 2008 
(8% Indigenous) (Ward 2011) found:
• Aboriginal and Torres Strait Islander status and female gender were associated with HCV seropositivity.
• Aboriginal and Torres Strait Islander participants reported higher rates of  risk behaviour than 
non-Indigenous participants, including:
• Receptive sharing of  needle syringes (21% vs 16%)
• Receptive sharing of  ancillary injecting equipment (38% vs 33%)
• Having been injected by others (18% vs 13%)
• Injecting in public places (54% vs 49%).
When restricted to Aboriginal and Torres Strait Islander participants only, factors independently associated with 
HCV antibody positivity included:
• Female gender
• Injecting drugs for more than three years
• Injecting in public in the past month
• Receptive sharing of  ancillary injecting equipment in the last month
• Having been incarcerated in the preceding year
• Current Opioid Substitution Treatment (OST).
Figure 46 Hepatitis C antibody prevalence and HIV antibody prevalence in Australian NSP Survey, by 
Aboriginal and Torres Strait Islander status
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Methodological notes
1 National surveillance for STIs
1.1 Notification of STI infections to the National Notifiable Diseases Surveillance System
Diagnoses of  specific STIs were notified by State/Territory health authorities to the National Notifiable Disease 
Surveillance System, maintained by the Australian Government Department of  Health. Chlamydia was notifiable 
in all health jurisdictions except New South Wales prior to 1998; chlamydia was made notifiable in New South 
Wales in 1998. Gonorrhoea was a notifiable condition in all health jurisdictions and infectious syphilis became 
notifiable in all jurisdictions in 2004. In most health jurisdictions, diagnoses of  STIs were notified by the 
diagnosing laboratory, the medical practitioner, hospital or a combination of  these sources (see Table below).
Table Source of notification of specific sexually transmissible infections to the National Notifiable 
Diseases Surveillance System by State/Territory
Diagnosis ACT NSW NT QLD SA TAS VIC WA
Gonorrhoea Doctor
Laboratory
Hospital
Laboratory Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Doctor
Laboratory
Infectious  Syphilis Doctor
Laboratory
Hospital
Doctor
Laboratory
Hospital
Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Doctor
Laboratory
Chlamydia Doctor
Laboratory
Hospital
Laboratory Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Laboratory Doctor
Laboratory
Doctor
Laboratory
Donovanosis Not notifiable Laboratory Doctor
Laboratory
Doctor
Laboratory
Hospital
Doctor
Laboratory
Laboratory Doctor
Laboratory
Doctor
Laboratory
1.2 National surveillance for STI infections among the Aboriginal and Torres Strait 
Islander population
Notifications of  gonorrhoea and infectious syphilis diagnoses was sought through doctors and laboratories in 
the Australian Capital Territory, New South Wales, the Northern Territory, Queensland South Australia, Victoria 
and Western Australia. Notifications of  chlamydia diagnoses were sought through doctors and laboratories in 
the Australian Capital Territory, the Northern Territory, Queensland, South Australia, and Western Australia. New 
South Wales, Tasmania and Victoria were the only health authorities that sought chlamydia notifications through 
laboratories only.
Population rates of  diagnosis of  specific STI infections were calculated by year and State/Territory of  diagnosis 
using Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 2001 – 2026 available through 
the Australian Bureau of  Statistics.
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1.3 Rate of diagnosis of STI infections by area of residence
The rate of  diagnosis of  STI infections in Australia in 2013 by area of  residence and Aboriginal and Torres Strait 
Islander status was calculated using the 2011 census population distribution, based on the Australian Standard 
Geographical Classification (ASGC). The ASGC uses Aria+ methodology, which assigns each locality to one of  
five remoteness classifications based on its distance by road to different categories of  service centre. The service 
centres are categorised according to population size. Hobart and Darwin are not category A service centres 
(service centres with a population size of  250 000 or above) and therefore are classed as “Inner Regional” and 
“Outer Regional” areas, respectively, based on their distance to the nearest category A service centre. The five 
remoteness classifications are: Major cities, Inner Regional, Outer Regional, Remote and Very Remote.
2 National surveillance for newly diagnosed HIV infection
2.1 National HIV Registry
Newly diagnosed HIV infection is a notifiable condition in each health jurisdiction in Australia. Cases of  newly 
diagnosed HIV infection were notified through State/Territory health authorities to the national HIV surveillance 
centre on the first occasion of  diagnosis in Australia. Information sought at notification of  HIV infection included 
State/Territory of  diagnosis, name code (based on the first two letters of  the family name and the first two letters 
of  the given name), sex, date of  birth, Aboriginal and Torres Strait Islander status, date of  HIV diagnosis, CD4+ 
cell count at diagnosis, source of  exposure to HIV and evidence of  newly acquired HIV infection. Information 
on country of  birth has been reported by all health jurisdictions for cases of  HIV infection newly diagnosed 
in Australia from 1 January 2002. Information on language spoken at home has been reported by health 
jurisdictions in New South Wales, Victoria and Queensland for cases of  HIV infection newly diagnosed from 1 
January 2004 and by all jurisdictions from 2008. Reporting of  a previous HIV diagnosis overseas was introduced 
for cases of  HIV infection newly diagnosed in Australia from 1 January 2007. Late HIV diagnosis was defined as 
newly diagnosed HIV infection with a CD4+ cell count of  less than 350 cells/µl. Advanced HIV diagnosis was 
defined as newly diagnosed HIV infection with a CD4+ cell count of  less than 200 cell/µl.
In New South Wales, information on cases of  newly diagnosed HIV infection was sought only from the 
diagnosing doctor prior to 2008. From 2008, information was also sought from the doctors to whom the person 
with HIV infection was referred, and follow up was carried out for cases for which the information sought at HIV 
notification was incomplete. These new procedures resulted in more complete information on new HIV diagnoses 
and reassignment of  cases found to have been newly diagnosed in earlier years.
The surveillance systems for newly diagnosed HIV infection are described in Guy et al (2007) and McDonald 
et al (1994b). The National Serology Reference Laboratory, Australia (Dax and Vandenbelt 1993), carried out 
monitoring of  HIV antibody testing.
2.2 National surveillance for newly diagnosed HIV infection among the Aboriginal 
and Torres Strait Islander population
Information on Aboriginal and Torres Strait Islander status was routinely sought at diagnosis of  HIV infection in 
the Northern Territory, Queensland, South Australia, Tasmania and Western Australia from 1985. Information on 
Aboriginal and Torres Strait Islander status was available for cases of  HIV infection newly diagnosed in New 
South Wales from January 1992, from June 1998 in Victoria and from January 2005 in the Australian Capital 
Territory. Nationally, information on Aboriginal and Torres Strait Islander status at diagnosis of  HIV infection was 
sought prospectively from May 1995. For HIV diagnoses prior to 1995, Aboriginal and Torres Strait Islander 
status was obtained retrospectively through health authorities. In 2000 – 2009, Aboriginal and Torres Strait 
Islander status was reported at HIV diagnosis by State/Territory health authorities other than the Australian 
Capital Territory prior to January 2005 and Victoria prior to June 1998 in 98% of  Australian-born cases. Further 
information is available in Guthrie et al (2000).
Population rates of  newly diagnosed HIV infection by Aboriginal and Torres Strait Islander status were calculated 
using Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 2001‑2026 (ABS 3238). 
The area of  residence by Aboriginal and Torres Strait Islander status was calculated using the 2011 census 
population distribution, based on the Australian Standard Geographical Classification. The rate of  HIV diagnosis 
in the non-Indigenous population included only those born in Australia.
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3 Global comparisons
The data in Figure 27 were obtained from the following sources:
• Centers for Disease Control and Prevention. HIV Surveillance Report, 2011; vol. 23. http://www.cdc.gov/hiv/
topics/surveillance/resources/reports/. Published February 2013. Accessed [10 September 2013]
• Health Protection Agency. HIV in the United Kingdom: 2012 Report: London: Health Protection Services, 
Colindale. November 2012.
• Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS 
epidemic 2012. UNAIDS, 2012. http://www.unaids.org
4 National surveillance for viral hepatitis
4.1 Notification of viral hepatitis to the National Notifiable Diseases Surveillance 
System
New HBV and HCV diagnoses were notifiable conditions in all health jurisdictions in Australia. Cases were notified 
by the diagnosing laboratory, medical practitioner, hospital or a combination of  these sources, through State/
Territory health authorities, to the National Notifiable Diseases Surveillance System. Population rates of  diagnosis 
of  viral hepatitis were calculated for each jurisdiction using yearly population estimates, provided by the Australian 
Bureau of  Statistics. HBV infection and HCV infection was classified as newly acquired if  evidence was available 
of  acquisition in the 24 months prior to diagnosis (The Department of  Health, Communicable Diseases Network 
Australia (CDNA), Australian national notifiable diseases case definitions. Last updated March 2014).
4.2 National surveillance for viral hepatitis among the Aboriginal and Torres Strait 
Islander population
Information was sought on Aboriginal and Torres Strait Islander status for diagnoses of  prevalent and newly 
acquired HBV, and prevalent and newly acquired HCV cases notified to the National Notifiable Diseases 
Surveillance System. Population rates of  diagnoses of  viral hepatitis were calculated by year and State/Territory 
of  diagnosis (in those jurisdictions for which Aboriginal and Torres Strait Islander status was reported in more 
than 50% of  diagnoses in each year 2009 – 2013) using Estimates and Projections, Aboriginal and Torres Strait 
Islander Australians, 2001‑2026 (ABS 3238).
4.3 HCV infection and chronic HBV seroprevalence among prison entrants
The National Prison Entrants’ Bloodborne Virus Survey (NPEBBVS) commenced in Australia in 2004 to provide 
ongoing data on infectious disease prevalence among people entering prisons from the community. It is a 
cross-sectional survey of  prison entrants that has been conducted over 2 week periods in 2004, 2007, 2010 and 
2013. Prison entrants from up to 29 reception prisons across Australia have contributed to the survey. Four states 
contributed to the survey in 2004: New South Wales, Queensland, Tasmania and Western Australia. By 2010, 
prisons in the Australian Capital Territory, the Northern Territory, South Australia, Tasmania and Victoria also 
contributed. All new receptions during the survey periods were invited to participate. Participants completed a 
short questionnaire on risk behaviour followed by blood testing. Crude prevalence estimates were calculated for 
HBsAg and anti-HCV.
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Collaboration of Australian Prisons
• ACT Alexander Maconochie Centre
• NSW Metropolitan Reception & Remand Centre (MRCC)
Mulawa Correctional Centre
Bathurst CC
Cessnock CC
Grafton CC
Goulburn CC
Silverwater Women’s CC
Tamworth CC
• NT Alice Springs CC
Darwin CC
• QLD Arthur Gorrie CC
Brisbane CC
Lotus Glen CC
Townsville CC
Capricornia CC
• SA Adelaide Remand Centre
Adelaide Women’s Prison
City Watch House
Port Augusta Prison
Port Lincoln
Yatala Labour Prison
• TAS Hobart Remand Centre
Launceston Reception Prison
Risdon Prison Complex
Mary Hutchinson’s Women’s Prison
• VIC Dame Phyllis Frost Centre
Melbourne Assessment Prison
• WA Hakea Prison
Bandyrup Women’s Prison
Roebourne Regional Prison
Greenough Regional Prison
4.4 HBV vaccination coverage at 12 and 24 months
The cohort method is used for calculating coverage at the population level. Cohort immunisation status is 
assessed at 12 months of  age (for vaccines due at 6 months), and 24 months of  age (for vaccines due at 
12 months). A minimum 3 month lag period is allowed for late notification of  immunisations to the Australian 
Childhood Immunisation Register (ACIR). Indigenous status on the ACIR is recorded as ‘Indigenous’, 
‘non-Indigenous’ or ‘unknown’, as reported by the child’s carer to Medicare, or by the immunisation provider to 
the ACIR. For this report children are categorised as: ‘Indigenous’ and ‘non-Indigenous’, children with unknown 
Indigenous status were presumed to be ‘non-Indigenous’.
4.5 HIV and HCV seroprevalence among people who inject drugs
All clients attending needle and syringe program (NSP) sites during one week in 2009 (51 sites), 2010 (52 
sites), 2011 (52 sites), 2012 (52 sites) and 2013 (50 sites) were asked to complete a brief, self-administered 
questionnaire and to provide a finger prick blood spot sample for HIV and HCV antibody testing. NSP sites were 
selected on the basis of  large numbers of  clients and representation from all State/Territory health jurisdictions. 
Further information is available in MacDonald et al (1997 and 2000).
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Collaboration of Australian Needle and Syringe Programs
• Directions ACT; Canberra.
• ACON Hunter; Central Coast NSP Services, Gosford, Long Jetty and Woy Woy; First Step Program, Port 
Kembla and Nowra; Health ConneXions, Liverpool; Hunter Harm Reduction Services, Newcastle; Kirketon 
Road Centre and Clinic 180, Kings Cross; Mid North Coast Harm Reduction, Coffs Harbour; Murrumbidgee 
Harm Reduction, Albury and Wagga Wagga; NSW Users and AIDS Association (NUAA), Surry Hills; 
Northern NSW Harm Reduction, Ballina, Byron Bay, Grafton, Lismore, Murwillumbah, Nimbin, and Tweed 
Heads; Resource and Education Program for IDUs, Redfern; Central Access Service, Kogarah and 
Sutherland; South Court Primary Care NSP, Nepean; Western Sydney HIV/Hepatitis C Prevention Service, 
Blacktown, Mt Druitt and Parramatta.
• Northern Territory AIDS and Hepatitis C Council, Alice Springs, Darwin and Palmerston, NT.
• Biala Community Alcohol and Drug Services, Brisbane; Cairns ATODS NSP, Cairns; Queensland Injectors 
Health Network (QuIHN), Brisbane, Gold Coast and Sunshine Coast; Kobi House, Toowoomba; West 
Moreton Sexual Health Service, Ipswich; Townsville ATODS NSP.
• Drug and Alcohol Services South Australia, Adelaide; Hindmarsh Centre, Hindmarsh; Nunkuwarrin Yunti 
Community Health Centre, Adelaide; South Australia Voice for Intravenous Education (SAVIVE): AIDS Council 
South Australia, Norwood; Parks Community Health Service, Adelaide; Port Adelaide Community Health 
Service, Port Adelaide; Noarlunga Community Health Service, Adelaide; Northern Metropolitan Community 
Health Service NSP and Shopfront, Salisbury.
• Anglicare NSP Service, Hobart and Glenorchy; Clarence Community Health Centre, Clarence; Devonport 
Community Health Centre, Devonport; Salvation Army Launceston, Launceston.
• Barwon Health Drug and Alcohol Services, Geelong; Health Information Exchange, St Kilda; Health Works, 
Footscray; Inner Space, Collingwood; North Richmond NSP, North Richmond; Southern Hepatitis/HIV/AIDS 
Resource and Prevention Service (SHARPS), Melbourne.
• WA AIDS Council Mobile Exchange, Perth; Western Australia Substance Users Association (WASUA), Perth 
and South Coast.
• St Vincent’s Centre for Applied Medical Research (AMR) and NSW State Reference Laboratory for HIV at St 
Vincent’s Hospital, Sydney, NSW.
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